Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,318 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.
Lahat A, Lang A, Ben-Horin S. Lahat A, et al. Digestion. 2012;85(1):1-8. doi: 10.1159/000332079. Epub 2011 Nov 17. Digestion. 2012. PMID: 22095142 Clinical Trial.
A schematic scale of health perception showed an improved score from 4.1 ± 1.43 to 7 ± 1.42 (p = 0.0002). Patients had a weight gain of 4.3 ± 2 kg during treatment (range 2-8; p = 0.0002) and an average rise in BMI of 1.4 ± 0.61 (range 0.8-2.7; p = 0.002). ...
A schematic scale of health perception showed an improved score from 4.1 ± 1.43 to 7 ± 1.42 (p = 0.0002). Patients had a weigh
Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease.
Ben-Horin S, Yavzori M, Kopylov U, Picard O, Fudim E, Eliakim R, Chowers Y, Lang A. Ben-Horin S, et al. J Crohns Colitis. 2011 Dec;5(6):555-8. doi: 10.1016/j.crohns.2011.05.006. J Crohns Colitis. 2011. PMID: 22115374
The level of infliximab was also measured in breast milk of a control group of 8 nursing healthy mothers. RESULTS: Infliximab was undetectable in breast milk prior to the first infusion and was also not measurable in 8 lactating women not exposed to infliximab. ...
The level of infliximab was also measured in breast milk of a control group of 8 nursing healthy mothers. RESULTS: Infliximab was und …
Functional voltage-gated sodium channels are expressed in human intestinal epithelial cells.
Barshack I, Levite M, Lang A, Fudim E, Picard O, Ben Horin S, Chowers Y. Barshack I, et al. Digestion. 2008;77(2):108-17. doi: 10.1159/000123840. Epub 2008 Apr 7. Digestion. 2008. PMID: 18391489
BACKGROUND AND AIM: Local anesthetics which preferentially interact with voltage-gated sodium channels (VGSCs) were shown to have a clinical beneficial effect in ulcerative colitis and to regulate the secretion of inflammatory mediators from intestinal epithelial cells. .. …
BACKGROUND AND AIM: Local anesthetics which preferentially interact with voltage-gated sodium channels (VGSCs) were shown to have a c …
Increasing the infliximab dose is beneficial in Crohn's disease patients who responded to a lower dose and relapsed.
Menachem Y, Avidan B, Lavy A, Lang A, Bardan E, Fidder H, Bar-Meir S, Chowers Y. Menachem Y, et al. Digestion. 2005;72(2-3):124-8. doi: 10.1159/000088367. Epub 2005 Sep 16. Digestion. 2005. PMID: 16172549
BACKGROUND: Relapse after an initial response to infliximab therapy poses a problem for maintenance treatment. AIM: To assess the effects of increasing the infliximab dosage in Crohn's disease (CD) patients who initially responded but flared during maintenance therapy. ... …
BACKGROUND: Relapse after an initial response to infliximab therapy poses a problem for maintenance treatment. AIM: To assess the eff …
Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients.
Fidder HH, Olschwang S, Avidan B, Zouali H, Lang A, Bardan E, Picard O, Bar-Meir S, Colombel JF, Chowers Y. Fidder HH, et al. Am J Med Genet A. 2003 Sep 1;121A(3):240-4. doi: 10.1002/ajmg.a.20209. Am J Med Genet A. 2003. PMID: 12923865
Genetic predisposition is a major risk factor in both diseases. The CARD15 (NOD2) gene has been implied as a candidate gene in the pathogenesis CD. ...
Genetic predisposition is a major risk factor in both diseases. The CARD15 (NOD2) gene has been implied as a candidate gene in …
Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure.
Ungar B, Haj-Natour O, Kopylov U, Yavzori M, Fudim E, Picard O, Loebstein R, Lahat A, Maor Y, Avidan B, Lang A, Weiss B, Chowers Y, Eliakim R, Ben-Horin S. Ungar B, et al. Medicine (Baltimore). 2015 May;94(18):e673. doi: 10.1097/MD.0000000000000673. Medicine (Baltimore). 2015. PMID: 25950682 Free PMC article.
However, among Crohn's disease patients, a non-stricturing non-penetrating phenotype was protective against ATI formation (OR 0.4, 95% CI 0.14-0.96, p = 0.04). ...These findings suggest a role for ethnicity, and implicitly for genetic predisposition, in modulating t …
However, among Crohn's disease patients, a non-stricturing non-penetrating phenotype was protective against ATI formation (OR 0.4, 95 …
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
Lang A, Salomon N, Wu JC, Kopylov U, Lahat A, Har-Noy O, Ching JY, Cheong PK, Avidan B, Gamus D, Kaimakliotis I, Eliakim R, Ng SC, Ben-Horin S. Lang A, et al. Clin Gastroenterol Hepatol. 2015 Aug;13(8):1444-9.e1. doi: 10.1016/j.cgh.2015.02.019. Epub 2015 Feb 24. Clin Gastroenterol Hepatol. 2015. PMID: 25724700 Clinical Trial.
METHODS: We performed a multicenter randomized, placebo-controlled, double-blind study of 50 mesalamine-treated patients with active mild-to-moderate UC (defined by the Simple Clinical Colitis Activity Index [SCCAI]) who did not respond to an additional 2 weeks of the maxi …
METHODS: We performed a multicenter randomized, placebo-controlled, double-blind study of 50 mesalamine-treated patients with active …
Severe and morbid obesity in Crohn's disease patients: prevalence and disease associations.
Ungar B, Kopylov U, Goitein D, Lahat A, Bardan E, Avidan B, Lang A, Maor Y, Eliakim R, Ben-Horin S. Ungar B, et al. Digestion. 2013;88(1):26-32. doi: 10.1159/000351529. Epub 2013 Jun 25. Digestion. 2013. PMID: 23816835
METHODS: A retrospective analysis of a computerized CD patient database was performed to identify severely/morbidly obese patients (BMI >35). ...Sleeve gastrectomy is a viable therapeutic option for morbidly obese CD patients....
METHODS: A retrospective analysis of a computerized CD patient database was performed to identify severely/morbidly obese pati …
Familial clustering of Crohn's disease in Israel: prevalence and association with disease severity.
Ben-Horin S, Avidan B, Yanai H, Lang A, Chowers Y, Bar-Meir S. Ben-Horin S, et al. Inflamm Bowel Dis. 2009 Feb;15(2):171-5. doi: 10.1002/ibd.20740. Inflamm Bowel Dis. 2009. PMID: 18839423
RESULTS: The study group consisted of 181 CD patients with a total of 825 1(st) degree relatives. Positive family history for IBD in a 1(st) degree relative was reported in 30 patients (16%). ...Having a positive family history of IBD has no impact on the sev …
RESULTS: The study group consisted of 181 CD patients with a total of 825 1(st) degree relatives. Positive family history for IBD in …
Travel-associated health risks for patients with inflammatory bowel disease.
Ben-Horin S, Bujanover Y, Goldstein S, Nadler M, Lang A, Kopylov U, Katz L, Lahat A, Schwartz E, Avidan B. Ben-Horin S, et al. Clin Gastroenterol Hepatol. 2012 Feb;10(2):160-5, 165.e1. doi: 10.1016/j.cgh.2011.10.025. Epub 2011 Nov 2. Clin Gastroenterol Hepatol. 2012. PMID: 22056299
METHODS: We performed a retrospective, case-controlled study of illnesses among 222 patients with IBD and 224 healthy individuals (controls) during 1099 total trips. ...CONCLUSIONS: Patients with IBD have a higher rate of illness compared with controls during trips …
METHODS: We performed a retrospective, case-controlled study of illnesses among 222 patients with IBD and 224 healthy individuals (co …
2,318 results
Jump to page
Feedback